Physician duties · PharmD · Connecticut
Signing for a Pharmacist in Connecticut: what the physician takes on
The agreement is mandatory for the clinician, which makes its duties mandatory for you. Connecticut calls the instrument a Collaborative Drug Therapy Management Agreement or Care Plan.
Represents Connecticut's pharmacist Collaborative Drug Therapy Management (CDTM) framework (§20-631), not ordinary licensure — base dispensing/counseling need no physician/APRN agreement and are out of scope here. Any 'qualified pharmacist' (competency requirement plus review of the national Pharmacists' Patient Care Process) may enter a CDTM agreement; no residency, board-certification, or numeric per-prescriber cap was found.
What you take on as the physician
The rules the physician relationship has to follow. Each fact comes from the statute or board rule listed under sources.
Proximity
Not codified — left to the agreement
Supervision ratio
Not codified — no cap on file
Chart review
Not codified — left to the agreement
Meeting cadence
Not codified — left to the agreement
Prescriptive authority
Covered by the practice agreement · no controlled-substance authority
§20-631's CDTM authority text does not mention controlled substances at all — this research pass found no confirmation that CDTM extends to Schedule II-V drugs; treat controlledSubstancesAllowed as an unconfirmed 'no' from statutory silence rather than a settled exclusion. Pharmacist must notify the prescribing practitioner within 24 hours of any discontinuance/deprescribing.
Written agreement
Required
The prescribing practitioner (physician or APRN) must first establish a provider-patient relationship with the patient before the pharmacist may act under a CDTM agreement, care plan, or institutional CDTM policy (§20-631(b)).
Practice ownership (corporate practice of medicine)
Non-licensee ownership permitted — No general pharmacist-ownership requirement — a pharmacy must be 'supervised and managed' by a full-time pharmacist-manager (§20-597), who retains professional control over dispensing, but the pharmacy itself may be non-pharmacist/corporate-owned.
One CT-specific restriction: no prescribing practitioner, their spouse (unless also a pharmacist), or their dependent child may hold an ownership/investment interest in a pharmacy (§20-596) — an anti-self-referral rule distinct from the CDTM clinical framework above.
Legal sources for these rules (4)
- Conn. Gen. Stat. § 20-631 — Collaborative Drug Therapy Care Plans, Management Agreements and Policies. Scope.
- Conn. Gen. Stat. § 20-631a — Collaborative Drug Management Agreements (Community Pharmacies Pilot Program)
- Conn. Gen. Stat. § 20-596 — Ownership of Pharmacies by Prescribing Practitionerssecondary
- Conn. Gen. Stat. § 20-597 — Pharmacy to be Supervised and Managed by Pharmacist
What physicians charge for this role
Typical monthly compensation in Connecticut
$500 – $600
Estimate for one Pharmacist. Standard-tier state.
About Connecticut's rules
NP, CNS, and CRNA are all licensed as a single 'advanced practice registered nurse' category (§20-94a) sharing an identical 3-year/2,000-hour collaboration-to-independence pathway (§20-87a); CT does not statutorily distinguish PMHNP or CNS scope from general NP. CNMs are licensed separately (Ch. 377), with no written collaborative-agreement requirement. No provider type below has a codified supervision ratio cap, chart-review percentage, or on-site proximity radius outside CRNA's surgery-specific carve-out.
Other clinicians in Connecticut: see the state overview.